Oral valganciclovir for symptomatic congenital cytomegalovirus infection in an extremely low birth weight infant

Journal of Perinatology

Volumn 28, Issue 1, 2008, Pages 74-76

  Muller A ^a   Eis Hubinger A M ^a   Brandhorst, G ^b   Heep, A ^a   Bartmann, P ^a   Franz, A R ^a  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL LUNG SURFACTANT; CYTOMEGALOVIRUS ANTIBODY; GANCICLOVIR; VALGANCICLOVIR;

APGAR SCORE; ARTICLE; CASE REPORT; CHOLESTASIS; CYTOMEGALOVIRUS INFECTION; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG WITHDRAWAL; EVOKED BRAIN STEM RESPONSE; EXTREMELY LOW BIRTH WEIGHT; HEPATITIS; HUMAN; HYPERBILIRUBINEMIA; INFANT; INTRAUTERINE GROWTH RETARDATION; LIVER FUNCTION TEST; MALE; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEUTROPENIA; NEWBORN; PREMATURITY; THROMBOCYTOPENIA;

ADMINISTRATION, ORAL; ADOLESCENT; ANTIVIRAL AGENTS; CYTOMEGALOVIRUS INFECTIONS; DISEASE TRANSMISSION, VERTICAL; FEMALE; FETAL GROWTH RETARDATION; GANCICLOVIR; HUMANS; INFANT, EXTREMELY LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, PREMATURE; INFUSIONS, INTRAVENOUS; MALE; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; VIRAL LOAD;

EID: 38049074462     PISSN: 07438346     EISSN: 14765543     Source Type: Journal    
DOI: 10.1038/sj.jp.7211854     Document Type: Article

References (7)

1. Kimberlin DW, Lin CY, Sanchez PJ, Demmler GJ, Dankner W, Shelton M et al. Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial. J Pediatr 2003; 143: 16-25.
2. Whitley RJ, Cloud G, Gruber W, Storch GA, Demmler GJ, Jacobs RF et al. Ganciclovir treatment of symptomatic congenital cytomegalovirus infection: Results of a phase II study. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. J Infect Dis 1997; 175: 1080-1086.
3. Michaels MG, Greenberg DP, Sabo DL, Wald ER. Treatment of children with congenital cytomegalovirus infection with ganciclovir. Pediatr Infect Dis J 2003; 22: 504-509.
4. Acosta EP, Brundage RC, King JR, Sanchez PJ, Sood S, Agrawal V et al. Ganciclovir population pharmacokinetics in neonates following intravenous administration of ganciclovir and oral administration of a liquid valganciclovir formulation. Clin Pharmacol Ther 2007; 81 867-872.
5. Meine Jansen CF, Toet MC, Rademaker CM, Ververs TF, Gerards LJ, van Loon AM. Treatment of symptomatic congenital cytomegalovirus infection with valganciclovir. J Perinal Med 2005; 33: 364-366.
6. Schulzke S, Buhrer C. Valganciclovir for treatment of congenital cytomegalovirus infection. Eur J Pediatr 2006; 165: 575-576.
7. Galli L, Novelli A, Chiappini E, Gervaso P, Casseta MI, Fallani S et al. Valganciclovir for congenital CMV infection: A pilot study on plasma concentration in newborns and infants. Pediatr Infect Dis J 2007; 26: 451-453.